Filippo Pietrantonio

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Filippo Pietrantonio

Sep 15, 2024, 09:40 | Societies

The final analysis of the KEYNOTE-811 trial presented at ESMO24

ESMO shared on LinkedIn: "As presented at ESMO24, the final analysis of the KEYNOTE-811 trial…

Sep 3, 2024, 13:11 | Insight

Julein Taieb: Real world evidence showing 50 MSI-H BRAF V600E mutant treated with immunotherapy

Julein Taieb, Professor, Paris Descartes University, shared a post on LinkedIn: "BRAFmutant, MSI, colorectal cancer…

Aug 7, 2024, 00:27 | Blog

Paolo Tarantino reflects on the results from DESTINY-CRC02 published in the Lancet Oncology

Paolo Tarantino shared on X: “Results from DESTINY-CRC02 published in the Lancet Oncology. Among patients…

Aug 5, 2024, 01:55 | Societies

Scientific Committees at the ESMO Congress 2024

The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…

Jul 21, 2024, 04:10 | OncoDaily Pulse

OncoDaily Party and Yvonne Award Photos - Part 1

On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…

Jul 2, 2024, 04:25 | OncoDaily Pulse

OncoDaily Party and Yvonne Award 2024 Photos - Part 2

On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…

Jun 21, 2024, 02:08 | Insight

New Paper Alert! AtezoTRIBE Study

AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…

Apr 18, 2024, 11:57 | Insight

New Paper Alert! The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based on Microsatellite Instability Status

The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based…

All: 8 Posts: 1 - 100